Visceral adiposity index is associated with silent brain infarct in a healthy population.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
14 10 2020
14 10 2020
Historique:
received:
11
06
2020
accepted:
30
09
2020
entrez:
15
10
2020
pubmed:
16
10
2020
medline:
13
3
2021
Statut:
epublish
Résumé
Visceral adiposity index (VAI) has been associated with various cardio-metabolic diseases; however, there is limited information about its association with cerebrovascular diseases. In this study, we evaluated the relationship between VAI and silent brain infarct (SBI). We evaluated a consecutive series of healthy volunteers over the age of 40 between January 2006 and December 2013. SBI was defined as an asymptomatic, well-defined lesion with a diameter ≥ 3 mm with the same signal characteristics as the cerebrospinal fluid. VAI was calculated using sex-specific equations as described in previous studies. A total of 2596 subjects were evaluated, and SBI was found in 218 (8%) participants. In multivariable analysis, VAI (adjusted odds ratio [aOR] = 1.30; 95% confidence interval [CI] 1.03-1.66; P = 0.030) remained a significant predictor of SBI after adjustment for confounders. The close relationship between VAI and SBI was prominent only in females (aOR = 1.44; 95% CI 1.00-2.07; P = 0.048). In the evaluation between VAI and the burden of SBI, VAI showed a positive dose-response relationship with the number of SBI lesions (P for trend = 0.037). High VAI was associated with a higher prevalence and burden of SBI in a neurologically healthy population.
Identifiants
pubmed: 33057150
doi: 10.1038/s41598-020-74454-6
pii: 10.1038/s41598-020-74454-6
pmc: PMC7566629
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
17271Références
J Atheroscler Thromb. 2019 Sep 1;26(9):821-834
pubmed: 30787215
Lipids Health Dis. 2011 Oct 19;10:183
pubmed: 22011564
JAMA. 2008 Nov 12;300(18):2142-52
pubmed: 19001625
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):467-73
pubmed: 22095978
Ann Med. 2016 Sep;48(6):410-416
pubmed: 27181508
J Diabetes Complications. 2020 Jun;34(6):107442
pubmed: 31668590
Lancet Neurol. 2010 Jul;9(7):689-701
pubmed: 20610345
PLoS One. 2014 Aug 08;9(8):e104365
pubmed: 25105797
Diabetes Metab Res Rev. 2018 Nov;34(8):e3052
pubmed: 30064156
Lancet Neurol. 2013 Aug;12(8):822-38
pubmed: 23867200
Diabetes Care. 2013 Aug;36(8):2294-300
pubmed: 23637352
Diabetes Care. 2010 Apr;33(4):920-2
pubmed: 20067971
Stroke. 2000 Aug;31(8):1882-8
pubmed: 10926951
Cardiovasc Diabetol. 2012 Mar 07;11:20
pubmed: 22394430
PLoS One. 2015 Apr 10;10(4):e0123414
pubmed: 25860643
Circulation. 1997 Jan 7;95(1):1-4
pubmed: 8994405
Lancet Neurol. 2007 Jul;6(7):611-9
pubmed: 17582361
PLoS One. 2014 Dec 05;9(12):e114112
pubmed: 25479351
Diabetol Metab Syndr. 2014 Dec 22;6(1):143
pubmed: 25587360
Int J Obes (Lond). 2020 Feb;44(2):362-367
pubmed: 31028293
J Neurol Sci. 2019 Sep 15;404:52-57
pubmed: 31326687
Stroke. 2010 Mar;41(3):550-3
pubmed: 20056924
Obesity (Silver Spring). 2013 Jan;21(1):203-9
pubmed: 23505187
Sci Rep. 2017 Aug 11;7(1):7951
pubmed: 28801558
Ann Med. 2006;38(1):52-63
pubmed: 16448989